大行评级｜大摩：上调默克目标价至132美元 Keytruda续强劲增长(da xing ping ji da mo shang diao mo ke mu biao jia zhi mei yuan xu qiang jing zeng zhang)

摩mó根gēn士shì丹dān利lì发fā表biǎo研yán究jiū报bào告gào指zhǐ，默mò克kè在zài抗kàng癌ái药yàoKeytruda的de支zhī持chí下xià，虽suī有yǒu来lái自zì外wài汇huì的de不bù利lì因yīn素sù，但dàn首shǒu季jì业yè绩jī再zài创chuàng佳jiā绩jī。该gāi行xíng上shàng调diào了le其qí对duì公gōng司sī的de2024年nián的de盈yíng测cè，并bìng将jiāng目mù标biāo价jià从cóng128美měi元yuán上shàng调diào至zhì132美měi元yuán，认rèn为wèi今jīn年nián剩shèng余yú时shí间jiān的de重zhòng点diǎn在zàiWinrevair的de上shàng市shì，初chū步bù评píng论lùn令lìng人rén鼓gǔ舞wǔ。该gāi行xíng予yǔ默mò克kè“与yǔ大dà市shì同tóng步bù”评píng级jí。报bào告gào指zhǐ，新xīn收shōu入rù指zhǐ引yǐn为wèi631亿yì元yuán至zhì643亿yì美měi元yuán，而ér该gāi行xíng将jiāng其qí预yù测cè由yóu645亿yì元yuán上shàng调diào至zhì650亿yì美měi元yuán，市shì场chǎng预yù期qī为wèi639亿yì美měi元yuán，包bāo括kuò了le来lái自zì外wài汇huì的de4亿yì美měi元yuán增zēng量liàng不bù利lì因yīn素sù。新xīn的de每měi股gǔ盈yíng利lì指zhǐ引yǐn落luò在zài8.53至zhì8.65美měi元yuán之zhī间jiān，相xiāng较jiào该gāi行xíng的de新xīn预yù测cè8.96美měi元yuán及jí市shì场chǎng预yù测cè的de8.57美měi元yuán，包bāo括kuò了le因yīn收shōu购gòuIPR&D而ér减jiǎn少shǎo的de0.26美měi元yuán，及jí减jiǎn去qù来lái自zì外wài汇huì风fēng险xiǎn的de0.05美měi元yuán。

v st

yle="text-align:center;">